Alnylam Pharmaceuticals, Inc. (ALNY)
USD 224.32
(-3.7%)
USD 224.32
(-3.7%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | -282.17 Million USD | 64.06% |
| 2022 | -785.07 Million USD | -10.78% |
| 2021 | -708.65 Million USD | 14.46% |
| 2020 | -828.43 Million USD | 11.81% |
| 2019 | -939.43 Million USD | -15.31% |
| 2018 | -814.67 Million USD | -62.91% |
| 2017 | -500.08 Million USD | -17.78% |
| 2016 | -424.58 Million USD | -43.44% |
| 2015 | -296 Million USD | 26.91% |
| 2014 | -404.98 Million USD | -335.73% |
| 2013 | -92.94 Million USD | 28.21% |
| 2012 | -129.45 Million USD | -136.16% |
| 2011 | -54.81 Million USD | -24.39% |
| 2010 | -44.07 Million USD | 8.4% |
| 2009 | -48.11 Million USD | -72.84% |
| 2008 | -27.83 Million USD | 70.13% |
| 2007 | -93.17 Million USD | -135.89% |
| 2006 | -39.5 Million USD | 9.13% |
| 2005 | -43.47 Million USD | -34.74% |
| 2004 | -32.26 Million USD | -28.76% |
| 2003 | -25.05 Million USD | -493.49% |
| 2002 | -4.22 Million USD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q3 | -76.9 Million USD | -258.2% |
| 2024 Q1 | -43.43 Million USD | 62.69% |
| 2024 Q2 | 48.61 Million USD | 211.92% |
| 2023 Q4 | -116.4 Million USD | -154.43% |
| 2023 Q3 | 213.86 Million USD | 193.05% |
| 2023 Q2 | -229.83 Million USD | -53.42% |
| 2023 Q1 | -149.8 Million USD | 20.57% |
| 2023 FY | -282.17 Million USD | 64.06% |
| 2022 Q4 | -188.61 Million USD | 26.91% |
| 2022 Q1 | -146.73 Million USD | 24.58% |
| 2022 Q2 | -191.68 Million USD | -30.64% |
| 2022 FY | -785.07 Million USD | -10.78% |
| 2022 Q3 | -258.04 Million USD | -34.62% |
| 2021 Q2 | -146.16 Million USD | 21.53% |
| 2021 Q3 | -181.67 Million USD | -24.3% |
| 2021 FY | -708.65 Million USD | 14.46% |
| 2021 Q4 | -194.56 Million USD | -7.09% |
| 2021 Q1 | -186.25 Million USD | 4.1% |
| 2020 Q2 | -198.85 Million USD | 5.38% |
| 2020 Q4 | -194.22 Million USD | 13.76% |
| 2020 Q3 | -225.19 Million USD | -13.25% |
| 2020 FY | -828.43 Million USD | 11.81% |
| 2020 Q1 | -210.15 Million USD | 29.49% |
| 2019 Q4 | -298.07 Million USD | -37.81% |
| 2019 FY | -939.43 Million USD | -15.31% |
| 2019 Q2 | -236.27 Million USD | -25.15% |
| 2019 Q1 | -188.78 Million USD | 14.33% |
| 2019 Q3 | -216.29 Million USD | 8.45% |
| 2018 Q3 | -254.55 Million USD | -32.34% |
| 2018 Q4 | -220.35 Million USD | 13.44% |
| 2018 FY | -814.67 Million USD | -62.91% |
| 2018 Q1 | -147.4 Million USD | -0.07% |
| 2018 Q2 | -192.35 Million USD | -30.49% |
| 2017 FY | -500.08 Million USD | -17.78% |
| 2017 Q2 | -120.47 Million USD | -13.11% |
| 2017 Q4 | -147.3 Million USD | -17.09% |
| 2017 Q3 | -125.8 Million USD | -4.42% |
| 2017 Q1 | -106.51 Million USD | 7.73% |
| 2016 Q4 | -115.43 Million USD | -8.21% |
| 2016 Q2 | -92.45 Million USD | 15.98% |
| 2016 FY | -424.58 Million USD | -43.44% |
| 2016 Q1 | -110.02 Million USD | -18.93% |
| 2016 Q3 | -106.67 Million USD | -15.39% |
| 2015 Q2 | -72.94 Million USD | -39.68% |
| 2015 Q4 | -92.51 Million USD | -18.11% |
| 2015 Q3 | -78.33 Million USD | -7.38% |
| 2015 FY | -296 Million USD | 26.91% |
| 2015 Q1 | -52.22 Million USD | -14.24% |
| 2014 Q2 | -45 Million USD | 83.27% |
| 2014 Q3 | -45.19 Million USD | -0.43% |
| 2014 Q4 | -45.71 Million USD | -1.13% |
| 2014 FY | -404.98 Million USD | -335.73% |
| 2014 Q1 | -269.06 Million USD | -809.25% |
| 2013 Q3 | -32.23 Million USD | -51.25% |
| 2013 Q1 | -9.8 Million USD | 88.9% |
| 2013 Q2 | -21.31 Million USD | -117.38% |
| 2013 FY | -92.94 Million USD | 28.21% |
| 2013 Q4 | -29.59 Million USD | 8.2% |
| 2012 Q4 | -88.34 Million USD | -386.85% |
| 2012 Q1 | -10.89 Million USD | 19.82% |
| 2012 Q3 | -18.14 Million USD | -50.39% |
| 2012 FY | -129.45 Million USD | -136.16% |
| 2012 Q2 | -12.06 Million USD | -10.78% |
| 2011 Q4 | -13.58 Million USD | -9.23% |
| 2011 Q2 | -13.11 Million USD | 16.32% |
| 2011 Q1 | -15.67 Million USD | -26.32% |
| 2011 FY | -54.81 Million USD | -24.39% |
| 2011 Q3 | -12.43 Million USD | 5.18% |
| 2010 Q3 | -8.72 Million USD | 24.93% |
| 2010 FY | -44.07 Million USD | 8.4% |
| 2010 Q1 | -11.3 Million USD | -40.12% |
| 2010 Q2 | -11.62 Million USD | -2.83% |
| 2010 Q4 | -12.41 Million USD | -42.19% |
| 2009 FY | -48.11 Million USD | -72.84% |
| 2009 Q4 | -8.06 Million USD | 16.38% |
| 2009 Q3 | -9.65 Million USD | 56.94% |
| 2009 Q2 | -22.41 Million USD | -180.85% |
| 2009 Q1 | -7.98 Million USD | -2.14% |
| 2008 Q1 | -3.95 Million USD | -36.83% |
| 2008 Q4 | -7.81 Million USD | -141.59% |
| 2008 Q3 | -3.23 Million USD | 74.8% |
| 2008 FY | -27.83 Million USD | 70.13% |
| 2008 Q2 | -12.83 Million USD | -224.26% |
| 2007 Q2 | -14.95 Million USD | 37.68% |
| 2007 Q4 | -2.89 Million USD | 94.37% |
| 2007 FY | -93.17 Million USD | -135.89% |
| 2007 Q1 | -23.99 Million USD | -140.16% |
| 2007 Q3 | -51.33 Million USD | -243.33% |
| 2006 Q3 | -8.6 Million USD | 22.55% |
| 2006 Q4 | -9.99 Million USD | -16.12% |
| 2006 Q1 | -9.79 Million USD | 34.32% |
| 2006 FY | -39.5 Million USD | 9.13% |
| 2006 Q2 | -11.1 Million USD | -13.39% |
| 2005 Q1 | -6.68 Million USD | -20.79% |
| 2005 Q4 | -14.91 Million USD | -39.8% |
| 2005 FY | -43.47 Million USD | -34.74% |
| 2005 Q3 | -10.67 Million USD | 4.77% |
| 2005 Q2 | -11.2 Million USD | -67.7% |
| 2004 Q1 | -13.33 Million USD | 35.22% |
| 2004 Q2 | -6.97 Million USD | 47.68% |
| 2004 FY | -32.26 Million USD | -28.76% |
| 2004 Q4 | -5.53 Million USD | 13.93% |
| 2004 Q3 | -6.42 Million USD | 7.87% |
| 2003 FY | -25.05 Million USD | -493.49% |
| 2003 Q4 | -20.58 Million USD | -46872.73% |
| 2003 Q2 | -3.26 Million USD | -50.14% |
| 2003 Q3 | 44 Thousand USD | 101.35% |
| 2003 Q1 | -2.17 Million USD | 0.0% |
| 2002 FY | -4.22 Million USD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Akebia Therapeutics, Inc. | -46.25 Million USD | -510.029% |
| Jaguar Health, Inc. | -34.29 Million USD | -722.884% |
| Keros Therapeutics, Inc. | -169.94 Million USD | -66.043% |
| Longboard Pharmaceuticals, Inc. | -56.75 Million USD | -397.146% |
| Ligand Pharmaceuticals Incorporated | 11.94 Million USD | 2462.879% |
| ContextLogic Inc. | -328 Million USD | 13.971% |
| MiMedx Group, Inc. | 37.11 Million USD | 860.252% |
| MEI Pharma, Inc. | 14.54 Million USD | 2040.414% |
| AlloVir, Inc. | -181.33 Million USD | -55.613% |
| Novavax, Inc. | -566.51 Million USD | 50.191% |
| Aptorum Group Limited | -10.52 Million USD | -2581.423% |
| Ardelyx, Inc. | -63.27 Million USD | -345.943% |
| Arrowhead Pharmaceuticals, Inc. | -205 Million USD | -37.645% |
| Psyence Biomedical Ltd. | -2.75 Million USD | -10154.104% |
| Vaxcyte, Inc. | -468.04 Million USD | 39.711% |
| Precigen, Inc. | -88.92 Million USD | -217.325% |
| Pharming Group N.V. | -4.87 Million USD | -5682.815% |
| Phathom Pharmaceuticals, Inc. | -167.31 Million USD | -68.652% |
| Pieris Pharmaceuticals, Inc. | -29.75 Million USD | -848.296% |
| Rigel Pharmaceuticals, Inc. | -20.49 Million USD | -1277.068% |
| Avidity Biosciences, Inc. | -235.59 Million USD | -19.77% |
| TransCode Therapeutics, Inc. | -19.41 Million USD | -1353.123% |
| Reviva Pharmaceuticals Holdings, Inc. | -24.3 Million USD | -1060.898% |
| Reviva Pharmaceuticals Holdings, Inc. | -24.3 Million USD | -1060.898% |
| Bicycle Therapeutics plc | -189.94 Million USD | -48.555% |
| Sangamo Therapeutics, Inc. | -274 Million USD | -2.982% |
| Sol-Gel Technologies Ltd. | -29.3 Million USD | -862.89% |
| Acelyrin, Inc. | -422.06 Million USD | 33.144% |
| SELLAS Life Sciences Group, Inc. | -37.86 Million USD | -645.135% |
| Sensei Biotherapeutics, Inc. | -37.06 Million USD | -661.318% |
| Senti Biosciences, Inc. | -92.72 Million USD | -204.307% |
| Stoke Therapeutics, Inc. | -114.77 Million USD | -145.855% |
| AbCellera Biologics Inc. | -237.2 Million USD | -18.957% |
| Alaunos Therapeutics, Inc. | -34.26 Million USD | -723.46% |
| BioXcel Therapeutics, Inc. | -171.78 Million USD | -64.263% |
| Entrada Therapeutics, Inc. | -3.16 Million USD | -8823.941% |
| Chimerix, Inc. | -93.06 Million USD | -203.202% |
| VistaGen Therapeutics, Inc. | -33.02 Million USD | -754.532% |
| Windtree Therapeutics, Inc. | -17.53 Million USD | -1508.843% |
| Corbus Pharmaceuticals Holdings, Inc. | -45.07 Million USD | -525.98% |
| Viracta Therapeutics, Inc. | -50.69 Million USD | -456.635% |
| Elevation Oncology, Inc. | -45.44 Million USD | -520.915% |
| Alkermes plc | 414.12 Million USD | 168.138% |
| Fortress Biotech, Inc. | -142.34 Million USD | -98.237% |
| Fortress Biotech, Inc. | -142.34 Million USD | -98.237% |
| Agenus Inc. | -159.54 Million USD | -76.858% |
| HOOKIPA Pharma Inc. | -97.69 Million USD | -188.836% |
| Dyadic International, Inc. | -8.22 Million USD | -3328.724% |
| ImmuCell Corporation | -5.74 Million USD | -4809.032% |
| Eton Pharmaceuticals, Inc. | -1.19 Million USD | -23572.399% |
| IDEAYA Biosciences, Inc. | -134.42 Million USD | -109.906% |
| Lantern Pharma Inc. | -17.87 Million USD | -1478.374% |
| Immix Biopharma, Inc. | -16.14 Million USD | -1648.176% |
| Incyte Corporation | 620.52 Million USD | 145.474% |
| IO Biotech, Inc. | -91.44 Million USD | -208.58% |
| Janux Therapeutics, Inc. | -72.97 Million USD | -286.652% |
| Inhibikase Therapeutics, Inc. | -20.08 Million USD | -1304.569% |
| Outlook Therapeutics, Inc. | -53.12 Million USD | -431.139% |
| Syros Pharmaceuticals, Inc. | -128.98 Million USD | -118.761% |
| Kintara Therapeutics, Inc. | -8.5 Million USD | -3219.315% |
| Barinthus Biotherapeutics plc | -83.91 Million USD | -236.267% |
| Madrigal Pharmaceuticals, Inc. | -380.49 Million USD | 25.84% |
| Sorrento Therapeutics, Inc. | -504.31 Million USD | 44.048% |
| NextCure, Inc. | -67.63 Million USD | -317.19% |
| Ocuphire Pharma, Inc. | -10.56 Million USD | -2571.353% |
| Onconetix, Inc. | -36.03 Million USD | -683.067% |
| Oncternal Therapeutics, Inc. | -41.71 Million USD | -576.452% |
| Opthea Limited | -191.84 Million USD | -47.087% |
| PDS Biotechnology Corporation | -43.04 Million USD | -555.531% |
| PureTech Health plc | -146.19 Million USD | -93.007% |
| Pyxis Oncology, Inc. | -82.19 Million USD | -243.295% |
| Seer, Inc. | -103.46 Million USD | -172.73% |
| Salarius Pharmaceuticals, Inc. | -12.89 Thousand USD | -2188161.442% |
| Clearside Biomedical, Inc. | -24.84 Million USD | -1035.787% |
| Telomir Pharmaceuticals, Inc. Common Stock | -3.94 Million USD | -7058.081% |
| VYNE Therapeutics Inc. | -29.25 Million USD | -864.437% |
| Wave Life Sciences Ltd. | -67.99 Million USD | -314.988% |
| Xeris Biopharma Holdings, Inc. | -44.01 Million USD | -541.161% |
| C4 Therapeutics, Inc. | -139.03 Million USD | -102.958% |
| ChromaDex Corporation | -5.59 Million USD | -4939.739% |
| TRACON Pharmaceuticals, Inc. | -6.89 Million USD | -3990.678% |
| Caribou Biosciences, Inc. | -116.05 Million USD | -143.131% |
| CRISPR Therapeutics AG | -222.53 Million USD | -26.799% |
| Precision BioSciences, Inc. | -43.73 Million USD | -545.178% |
| Fate Therapeutics, Inc. | -190.51 Million USD | -48.115% |
| Innoviva, Inc. | 176.7 Million USD | 259.683% |
| Summit Therapeutics Inc. | -89.73 Million USD | -214.45% |
| Verrica Pharmaceuticals Inc. | -65.75 Million USD | -329.105% |
| Aadi Bioscience, Inc. | -71.93 Million USD | -292.275% |
| ESSA Pharma Inc. | -32.13 Million USD | -778.117% |
| GlycoMimetics, Inc. | -39.27 Million USD | -618.454% |
| GT Biopharma, Inc. | -13.57 Million USD | -1978.484% |
| Inhibrx Biosciences, Inc. | -219.22 Million USD | -28.717% |
| Catalyst Pharmaceuticals, Inc. | 86.81 Million USD | 425.041% |
| Orchestra BioMed Holdings, Inc. | -51.5 Million USD | -447.849% |
| Alzamend Neuro, Inc. | -9.93 Million USD | -2739.455% |
| Rocket Pharmaceuticals, Inc. | -259.65 Million USD | -8.671% |
| Aptose Biosciences Inc. | -52.35 Million USD | -438.954% |
| ZyVersa Therapeutics, Inc. | -14.42 Million USD | -1856.726% |
| Soligenix, Inc. | -7.69 Million USD | -3565.591% |
| Century Therapeutics, Inc. | -146.54 Million USD | -92.55% |
| Kura Oncology, Inc. | -165.8 Million USD | -70.186% |
| TScan Therapeutics, Inc. | -93.45 Million USD | -201.927% |
| Intensity Therapeutics, Inc. | -8.31 Million USD | -3291.934% |
| Ocean Biomedical, Inc. | -2.48 Million USD | -11270.51% |
| CytomX Therapeutics, Inc. | -6.48 Million USD | -4251.866% |
| Autolus Therapeutics plc | -195.02 Million USD | -44.684% |
| Mineralys Therapeutics, Inc. | -84.65 Million USD | -233.316% |
| EyePoint Pharmaceuticals, Inc. | -73.66 Million USD | -283.067% |
| Eterna Therapeutics Inc. | -21.13 Million USD | -1235.108% |
| Adaptive Biotechnologies Corporation | -227.03 Million USD | -24.287% |
| GRI Bio, Inc. | -11.38 Million USD | -2378.045% |
| Xenetic Biosciences, Inc. | -4.51 Million USD | -6148.734% |
| Tenaya Therapeutics, Inc. | -131.19 Million USD | -115.084% |
| IGM Biosciences, Inc. | -263.46 Million USD | -7.103% |
| INmune Bio, Inc. | -29.74 Million USD | -848.774% |
| Heron Therapeutics, Inc. | -110.61 Million USD | -155.097% |
| SAB Biotherapeutics, Inc. | -38.07 Million USD | -641.097% |
| Pasithea Therapeutics Corp. | -15.97 Million USD | -1665.872% |
| Entero Therapeutics, Inc. | -15.77 Million USD | -1689.221% |
| Milestone Pharmaceuticals Inc. | -61.09 Million USD | -361.84% |
| X4 Pharmaceuticals, Inc. | -107.52 Million USD | -162.435% |
| Atara Biotherapeutics, Inc. | -276 Million USD | -2.235% |
| Coherus BioSciences, Inc. | -203.19 Million USD | -38.866% |
| Verastem, Inc. | -92.08 Million USD | -206.432% |
| Abeona Therapeutics Inc. | -47.13 Million USD | -498.653% |
| Pliant Therapeutics, Inc. | -184.14 Million USD | -53.235% |
| Tonix Pharmaceuticals Holding Corp. | -118.38 Million USD | -138.364% |
| Histogen Inc. | -10.64 Million USD | -2551.273% |
| Aprea Therapeutics, Inc. | -15.47 Million USD | -1723.783% |
| Surrozen, Inc. | -45.78 Million USD | -516.372% |
| Organovo Holdings, Inc. | -15.08 Million USD | -1770.443% |
| Lixte Biotechnology Holdings, Inc. | -5.09 Million USD | -5443.456% |
| Ovid Therapeutics Inc. | -59.28 Million USD | -375.992% |
| Panbela Therapeutics, Inc. | -51.29 Million USD | -450.113% |
| CASI Pharmaceuticals, Inc. | -25.28 Million USD | -1016.199% |
| Cadrenal Therapeutics, Inc. Common Stock | -7.63 Million USD | -3596.853% |
| Centessa Pharmaceuticals plc | -171.28 Million USD | -64.742% |
| Hepion Pharmaceuticals, Inc. | -48.44 Million USD | -482.429% |
| Arcturus Therapeutics Holdings Inc. | -78.2 Million USD | -260.815% |
| BioRestorative Therapies, Inc. | -15.22 Million USD | -1753.881% |
| Apollomics, Inc. | -54.83 Million USD | -414.599% |
| Amarin Corporation plc | -67.58 Million USD | -317.493% |
| Mesoblast Limited | -58.79 Million USD | -379.938% |
| Turnstone Biologics Corp. | -59.03 Million USD | -378.003% |
| Kymera Therapeutics, Inc. | -165.53 Million USD | -70.468% |
| Synaptogenix, Inc. | -8.31 Million USD | -3294.034% |
| Tiziana Life Sciences Ltd | -14.58 Million USD | -1834.561% |
| Aurinia Pharmaceuticals Inc. | -91.69 Million USD | -207.746% |
| BriaCell Therapeutics Corp. | -4.79 Million USD | -5789.116% |
| Monopar Therapeutics Inc. | -8.83 Million USD | -3095.193% |
| Exelixis, Inc. | 170.88 Million USD | 265.126% |
| Better Therapeutics, Inc. | -38.26 Million USD | -637.481% |
| Nurix Therapeutics, Inc. | -155.06 Million USD | -81.974% |
| Apellis Pharmaceuticals, Inc. | -517.12 Million USD | 45.433% |
| NLS Pharmaceutics AG | -11.8 Million USD | -2289.883% |
| Dermata Therapeutics, Inc. | -8.04 Million USD | -3408.807% |
| Aridis Pharmaceuticals, Inc. | -29.99 Million USD | -840.803% |
| Gritstone bio, Inc. | -154.63 Million USD | -82.479% |
| Jasper Therapeutics, Inc. | -68.86 Million USD | -309.775% |
| TNF Pharmaceuticals, Inc. | -17.12 Million USD | -1547.925% |
| Avid Bioservices, Inc. | -18.67 Million USD | -1410.735% |
| Insmed Incorporated | -709.62 Million USD | 60.236% |
| Virpax Pharmaceuticals, Inc. | -15.68 Million USD | -1698.463% |
| MediWound Ltd. | -15.29 Million USD | -1745.487% |
| OmniAb, Inc. | -69.41 Million USD | -306.481% |
| Alector, Inc. | -151.74 Million USD | -85.96% |
| Seres Therapeutics, Inc. | -107.98 Million USD | -161.314% |
| Checkpoint Therapeutics, Inc. | -52.14 Million USD | -441.104% |
| Zai Lab Limited | -366.57 Million USD | 23.024% |
| Revance Therapeutics, Inc. | -316.77 Million USD | 10.923% |
| Aura Biosciences, Inc. | -84.99 Million USD | -232.006% |
| Lyell Immunopharma, Inc. | -245.49 Million USD | -14.939% |
| Immunic, Inc. | -99.22 Million USD | -184.385% |
| Tarsus Pharmaceuticals, Inc. | -143.15 Million USD | -97.107% |
| Veracyte, Inc. | -85.79 Million USD | -228.894% |
| InMed Pharmaceuticals Inc. | - USD | Infinity% |
| FibroGen, Inc. | -281.81 Million USD | -0.128% |
| SeaStar Medical Holding Corporation | -14.21 Million USD | -1885.749% |
| Adial Pharmaceuticals, Inc. | -6.88 Million USD | -3996.649% |
| Sonnet BioTherapeutics Holdings, Inc. | -18.79 Million USD | -1401.521% |
| Jazz Pharmaceuticals plc | 578.58 Million USD | 148.77% |
| Cyclacel Pharmaceuticals, Inc. | -25.45 Million USD | -1008.612% |
| Amylyx Pharmaceuticals, Inc. | 38.8 Million USD | 827.218% |
| TG Therapeutics, Inc. | 20.63 Million USD | 1467.591% |
| Galecto, Inc. | -39.9 Million USD | -607.117% |
| Calithera Biosciences, Inc. | -42.07 Million USD | -570.664% |
| Fortrea Holdings Inc. | 63.1 Million USD | 547.187% |
| KalVista Pharmaceuticals, Inc. | -140.44 Million USD | -100.915% |
| Aptevo Therapeutics Inc. | -28.87 Million USD | -877.128% |
| XBiotech Inc. | -37.51 Million USD | -652.266% |
| Jasper Therapeutics, Inc. | -68.86 Million USD | -309.775% |
| Lyra Therapeutics, Inc. | -67.12 Million USD | -320.404% |
| Foghorn Therapeutics Inc. | -107.9 Million USD | -161.501% |
| Y-mAbs Therapeutics, Inc. | -25.67 Million USD | -999.155% |
| Theravance Biopharma, Inc. | -53.29 Million USD | -429.488% |
| Ultragenyx Pharmaceutical Inc. | -569.2 Million USD | 50.427% |
| Metagenomi, Inc. Common Stock | -78.49 Million USD | -259.495% |
| Vaxxinity, Inc. | -58.28 Million USD | -384.13% |
| BioCryst Pharmaceuticals, Inc. | -103.7 Million USD | -172.083% |
| Gain Therapeutics, Inc. | -22.25 Million USD | -1168.024% |
| Cartesian Therapeutics, Inc. | -86.41 Million USD | -226.531% |
| NexImmune, Inc. | -29.19 Million USD | -866.602% |
| Creative Medical Technology Holdings, Inc. | -5.62 Million USD | -4920.79% |
| Marker Therapeutics, Inc. | -14.58 Million USD | -1835.174% |
| Regeneron Pharmaceuticals, Inc. | 4.04 Billion USD | 106.972% |
| Chemomab Therapeutics Ltd. | -25.45 Million USD | -1008.351% |
| Scopus BioPharma Inc. | -11.71 Million USD | -2308.689% |
| RAPT Therapeutics, Inc. | -127.06 Million USD | -122.077% |
| Ainos, Inc. | -13.2 Million USD | -2036.654% |
| Pluri Inc. | -22.15 Million USD | -1173.468% |
| Prothena Corporation plc | -191.03 Million USD | -47.708% |
| Adaptimmune Therapeutics plc | -138.03 Million USD | -104.418% |
| Celularity Inc. | -192.28 Million USD | -46.747% |
| Rallybio Corporation | -78.93 Million USD | -257.491% |
| Cue Biopharma, Inc. | -52.14 Million USD | -441.094% |
| MeiraGTx Holdings plc | -137.06 Million USD | -105.875% |
| Omeros Corporation | -164.53 Million USD | -71.504% |
| Humacyte, Inc. | -100.04 Million USD | -182.042% |
| Immunocore Holdings plc | -59.64 Million USD | -373.059% |
| Cocrystal Pharma, Inc. | -18.55 Million USD | -1420.421% |
| Cidara Therapeutics, Inc. | -24.48 Million USD | -1052.534% |
| Blueprint Medicines Corporation | -486.27 Million USD | 41.972% |
| CalciMedica, Inc. | -21.87 Million USD | -1189.943% |
| Cabaletta Bio, Inc. | -74.66 Million USD | -277.947% |
| Marinus Pharmaceuticals, Inc. | -131.48 Million USD | -114.606% |
| Scholar Rock Holding Corporation | -171.29 Million USD | -64.73% |
| Sana Biotechnology, Inc. | -326.9 Million USD | 13.682% |
| Pulmatrix, Inc. | -14.74 Million USD | -1814.349% |
| Elicio Therapeutics, Inc. | -35.74 Million USD | -689.411% |
| Vigil Neuroscience, Inc. | -88.86 Million USD | -217.529% |
| Intellia Therapeutics, Inc. | -515.29 Million USD | 45.24% |
| Adlai Nortye Ltd. American Depositary Shares | -67.55 Million USD | -317.721% |
| Cytokinetics, Incorporated | -496.2 Million USD | 43.133% |
| Eloxx Pharmaceuticals, Inc. | -34.41 Million USD | -719.823% |
| Nutriband Inc. | -4.87 Million USD | -5691.857% |
| Protara Therapeutics, Inc. | -43.61 Million USD | -546.997% |
| Vor Biopharma Inc. | -126.03 Million USD | -123.884% |
| Roivant Sciences Ltd. | 4.24 Billion USD | 106.652% |
| Evogene Ltd. | -26.39 Million USD | -969.209% |
| ProKidney Corp. | -151.52 Million USD | -86.227% |
| Applied Therapeutics, Inc. | -64.53 Million USD | -337.243% |
| Hoth Therapeutics, Inc. | -7.69 Million USD | -3568.306% |
| BridgeBio Pharma, Inc. | -607.37 Million USD | 53.541% |
| CorMedix Inc. | -48.95 Million USD | -476.364% |
| BioLineRx Ltd. | -49.69 Million USD | -467.825% |
| Tango Therapeutics, Inc. | -114.17 Million USD | -147.147% |
| Galectin Therapeutics Inc. | -38.07 Million USD | -641.161% |
| Atai Life Sciences N.V. | -125.47 Million USD | -124.893% |
| Renovaro Biosciences Inc. | -81.63 Million USD | -245.636% |
| Aerovate Therapeutics, Inc. | -81.4 Million USD | -246.614% |
| Zentalis Pharmaceuticals, Inc. | -248.98 Million USD | -13.329% |
| Sagimet Biosciences Inc. | -30.74 Million USD | -817.941% |
| MediciNova, Inc. | -9.9 Million USD | -2750.176% |
| Praxis Precision Medicines, Inc. | -126.37 Million USD | -123.287% |
| Cardio Diagnostics Holdings, Inc. | -7.24 Million USD | -3796.121% |
| GeoVax Labs, Inc. | -26.74 Million USD | -955.138% |
| Axsome Therapeutics, Inc. | -231.82 Million USD | -21.719% |
| Biomea Fusion, Inc. | -126.13 Million USD | -123.709% |
| PTC Therapeutics, Inc. | -349.4 Million USD | 19.241% |
| Mereo BioPharma Group plc | -28.41 Million USD | -893.014% |
| Cullinan Oncology, Inc. | -191.08 Million USD | -47.667% |
| Syndax Pharmaceuticals, Inc. | -229.95 Million USD | -22.709% |
| Absci Corporation | -115.51 Million USD | -144.276% |
| NRx Pharmaceuticals, Inc. | -27.58 Million USD | -922.855% |
| 4D Molecular Therapeutics, Inc. | -112.86 Million USD | -150.007% |
| Dyne Therapeutics, Inc. | -242.16 Million USD | -16.523% |
| Kiniksa Pharmaceuticals, Ltd. | -25.19 Million USD | -1019.92% |
| Ventyx Biosciences, Inc. | -207.99 Million USD | -35.665% |
| Allakos Inc. | -196.05 Million USD | -43.926% |
| Imunon, Inc. | -21.03 Million USD | -1241.746% |
| Fulcrum Therapeutics, Inc. | -110.66 Million USD | -154.984% |
| Corcept Therapeutics Incorporated | 107.28 Million USD | 363.022% |
| BioAtla, Inc. | -129.68 Million USD | -117.582% |
| NLS Pharmaceutics AG | -11.8 Million USD | -2289.883% |
| Bio-Path Holdings, Inc. | -15.84 Million USD | -1681.071% |
| Allogene Therapeutics, Inc. | -327.73 Million USD | 13.902% |
| Larimar Therapeutics, Inc. | -41.75 Million USD | -575.739% |
| XOMA Corporation | -41.84 Million USD | -574.286% |
| Kezar Life Sciences, Inc. | -105.23 Million USD | -168.133% |
| Cara Therapeutics, Inc. | -121.49 Million USD | -132.252% |
| aTyr Pharma, Inc. | -54.91 Million USD | -413.802% |
| Aligos Therapeutics, Inc. | -87.42 Million USD | -222.755% |
| Akero Therapeutics, Inc. | -172.87 Million USD | -63.23% |
| Viridian Therapeutics, Inc. | -254.45 Million USD | -10.896% |
| Eliem Therapeutics, Inc. | -21.46 Million USD | -1214.521% |
| EyeGate Pharmaceuticals, Inc. | -8.21 Million USD | -3335.814% |
| Akari Therapeutics, Plc | -16.8 Million USD | -1579.013% |
| Tevogen Bio Holdings Inc. | -8843.03 USD | -3190831.163% |
| Halozyme Therapeutics, Inc. | 337.57 Million USD | 183.589% |
| Lexaria Bioscience Corp. | -6.53 Million USD | -4218.55% |
| UroGen Pharma Ltd. | -65.53 Million USD | -330.565% |
| Sutro Biopharma, Inc. | -89.27 Million USD | -216.063% |
| ZIVO Bioscience, Inc. | -7.26 Million USD | -3785.096% |
| Orgenesis Inc. | -53.63 Million USD | -426.093% |
| Entera Bio Ltd. | -8.89 Million USD | -3073.715% |
| GH Research PLC | -41.22 Million USD | -584.525% |
| Lisata Therapeutics, Inc. | -25.7 Million USD | -997.616% |
| Reneo Pharmaceuticals, Inc. | -83.05 Million USD | -239.753% |
| Xencor, Inc. | -138.63 Million USD | -103.532% |
| 60 Degrees Pharmaceuticals, Inc. | -5.15 Million USD | -5374.255% |
| Replimune Group, Inc. | -234.77 Million USD | -20.191% |
| Coeptis Therapeutics Holdings, Inc. | -21.49 Million USD | -1212.984% |
| Vanda Pharmaceuticals Inc. | -13.95 Million USD | -1922.47% |
| Lexaria Bioscience Corp. | -6.53 Million USD | -4218.55% |
| Portage Biotech Inc. | -18.25 Million USD | -1445.91% |
| Cardio Diagnostics Holdings, Inc. | -7.24 Million USD | -3796.121% |
| Olema Pharmaceuticals, Inc. | -104.96 Million USD | -168.838% |
| OncoCyte Corporation | -25.13 Million USD | -1022.593% |
| Qualigen Therapeutics, Inc. | -11.3 Million USD | -2396.051% |
| Processa Pharmaceuticals, Inc. | -11.45 Million USD | -2362.892% |
| Purple Biotech Ltd. | 22.27 Million USD | 1367.006% |
| CollPlant Biotechnologies Ltd. | -7.51 Million USD | -3656.323% |
| scPharmaceuticals Inc. | -55.39 Million USD | -409.378% |
| ProMIS Neurosciences, Inc. | -18.89 Million USD | -1393.172% |
| HilleVax, Inc. | -133.34 Million USD | -111.613% |
| NeuroSense Therapeutics Ltd. | -12.04 Million USD | -2241.896% |
| Tharimmune, Inc. | -9.45 Million USD | -2884.33% |
| Genprex, Inc. | -31.07 Million USD | -808.028% |
| Neumora Therapeutics, Inc. Common Stock | -188.19 Million USD | -49.938% |
| Atossa Therapeutics, Inc. | -31.37 Million USD | -799.305% |
| XTL Biopharmaceuticals Ltd. | -765 Thousand USD | -36785.621% |
| Virios Therapeutics, Inc. | -5.44 Million USD | -5080.452% |
| OKYO Pharma Limited | -15.74 Thousand USD | -1791518.015% |
| Savara Inc. | -60 Million USD | -370.237% |
| Curis, Inc. | -48.33 Million USD | -483.826% |
| Daré Bioscience, Inc. | -30.83 Million USD | -814.968% |
| Carmell Therapeutics Corporation | -5.21 Million USD | -5308.47% |
| Titan Pharmaceuticals, Inc. | -7.27 Million USD | -3777.628% |
| Achieve Life Sciences, Inc. | -27.25 Million USD | -935.505% |
| BeiGene, Ltd. | -1.2 Billion USD | 76.636% |
| Kiromic BioPharma, Inc. | -19.93 Million USD | -1315.17% |
| Revolution Medicines, Inc. Warrant | -487.18 Million USD | 42.081% |
| Protagonist Therapeutics, Inc. | -93.65 Million USD | -201.302% |
| Erasca, Inc. | -141.52 Million USD | -99.382% |
| bluebird bio, Inc. | -244.26 Million USD | -15.521% |
| Protagenic Therapeutics, Inc. | -4.52 Million USD | -6133.192% |
| BioMarin Pharmaceutical Inc. | 194.44 Million USD | 245.121% |
| DBV Technologies S.A. | -76.43 Million USD | -269.184% |
| Protagenic Therapeutics, Inc. | -4.52 Million USD | -6133.192% |
| Moderna, Inc. | -4.23 Billion USD | 93.343% |
| Vincerx Pharma, Inc. | -42.6 Million USD | -562.243% |
| Fresh Tracks Therapeutics, Inc. | -6.36 Million USD | -4336.714% |
| Molecular Templates, Inc. | -10.46 Million USD | -2596.111% |
| Acrivon Therapeutics, Inc. Common Stock | -67.23 Million USD | -319.672% |
| Travere Therapeutics, Inc. | -376.74 Million USD | 25.102% |
| Monte Rosa Therapeutics, Inc. | -143.31 Million USD | -96.897% |
| Spruce Biosciences, Inc. | -51.99 Million USD | -442.717% |
| Celldex Therapeutics, Inc. | -154.54 Million USD | -82.588% |
| Cogent Biosciences, Inc. | -208.13 Million USD | -35.576% |
| MacroGenics, Inc. | -168.24 Million USD | -67.718% |
| RenovoRx, Inc. | -11.39 Million USD | -2376.088% |
| Adicet Bio, Inc. | -152.03 Million USD | -85.595% |
| Prime Medicine, Inc. | -191.29 Million USD | -47.51% |
| Aditxt, Inc. | -26.06 Million USD | -982.689% |
| Adagene Inc. | -23.71 Million USD | -1089.615% |
| Estrella Immunopharma, Inc. | -7.31 Million USD | -3760.071% |
| Quantum-Si incorporated | -111.17 Million USD | -153.821% |
| Maravai LifeSciences Holdings, Inc. | -31.64 Million USD | -791.605% |
| Acurx Pharmaceuticals, Inc. | -14.57 Million USD | -1835.653% |
| Voyager Therapeutics, Inc. | 122.01 Million USD | 331.264% |
| SciSparc Ltd. | -5.77 Million USD | -4787.84% |
| Vericel Corporation | -6.46 Million USD | -4265.331% |
| Revelation Biosciences, Inc. | -8.65 Million USD | -3159.627% |
| Minerva Neurosciences, Inc. | -23.11 Million USD | -1120.502% |
| Generation Bio Co. | -138.56 Million USD | -103.644% |
| Astria Therapeutics, Inc. | -83.03 Million USD | -239.847% |
| Black Diamond Therapeutics, Inc. | -86.46 Million USD | -226.365% |
| Arcutis Biotherapeutics, Inc. | -241.1 Million USD | -17.036% |
| Invivyd, Inc. | -207.78 Million USD | -35.803% |
| Relay Therapeutics, Inc. | -373 Million USD | 24.35% |
| Quoin Pharmaceuticals, Ltd. | -9.37 Million USD | -2908.742% |
| Spero Therapeutics, Inc. | 21.48 Million USD | 1413.603% |
| Artelo Biosciences, Inc. | -10.28 Million USD | -2643.025% |
| 2seventy bio, Inc. | -216.7 Million USD | -30.213% |
| ADMA Biologics, Inc. | 21.63 Million USD | 1404.433% |
| Clene Inc. | -40.54 Million USD | -596.041% |
| Capricor Therapeutics, Inc. | -24.07 Million USD | -1071.927% |
| Boundless Bio, Inc. Common Stock | -54.79 Million USD | -414.955% |
| GeoVax Labs, Inc. | -26.74 Million USD | -955.138% |
| Recursion Pharmaceuticals, Inc. | -350.06 Million USD | 19.392% |
| Citius Pharmaceuticals, Inc. | -36.73 Million USD | -668.199% |
| Contineum Therapeutics, Inc. Class A Common Stock | 16.07 Million USD | 1855.147% |
| Relmada Therapeutics, Inc. | -103.7 Million USD | -172.102% |
| Finch Therapeutics Group, Inc. | -34 Million USD | -729.878% |
| ALX Oncology Holdings Inc. | -170.27 Million USD | -65.714% |
| Vir Biotechnology, Inc. | -684.3 Million USD | 58.765% |
| Evaxion Biotech A/S | -22.19 Million USD | -1171.23% |
| Ocular Therapeutix, Inc. | -82.38 Million USD | -242.52% |
| Verve Therapeutics, Inc. | -223.12 Million USD | -26.466% |
| Trevena, Inc. | -35.28 Million USD | -699.634% |
| Surrozen, Inc. | -45.78 Million USD | -516.372% |
| Tyra Biosciences, Inc. | -79.94 Million USD | -252.961% |
| Cingulate Inc. | -22.75 Million USD | -1139.829% |
| Galmed Pharmaceuticals Ltd. | 7.49 Million USD | 3866.351% |
| Unity Biotechnology, Inc. | -44.66 Million USD | -531.73% |
| Tenax Therapeutics, Inc. | -8.23 Million USD | -3326.974% |
| Terns Pharmaceuticals, Inc. | -102.55 Million USD | -175.137% |
| ACADIA Pharmaceuticals Inc. | -73.37 Million USD | -284.545% |
| Connect Biopharma Holdings Limited | -62.07 Million USD | -354.578% |
| Clearmind Medicine Inc. | -8.74 Million USD | -3128.048% |
| Kronos Bio, Inc. | -121.83 Million USD | -131.614% |
| Bolt Biotherapeutics, Inc. | -76.19 Million USD | -270.328% |
| CERo Therapeutics Holdings, Inc. | -2.93 Million USD | -9520.745% |
| Viking Therapeutics, Inc. | -100.82 Million USD | -179.861% |
| Statera Biopharma, Inc. | -98.34 Million USD | -186.927% |
| ImmunityBio, Inc. | -362.25 Million USD | 22.105% |
| Korro Bio, Inc. | -84.53 Million USD | -233.801% |
| Kineta, Inc. | -15.72 Million USD | -1694.664% |
| BioVie Inc. | -32.17 Million USD | -776.876% |
| Codexis, Inc. | -68.06 Million USD | -314.543% |
| Celularity Inc. | -192.28 Million USD | -46.747% |
| Crinetics Pharmaceuticals, Inc. | -222.6 Million USD | -26.759% |
| Celcuity Inc. | -66.23 Million USD | -326.051% |
| Virax Biolabs Group Limited | -6.49 Million USD | -4243.511% |
| Cibus, Inc. | -318.88 Million USD | 11.511% |
| Eledon Pharmaceuticals, Inc. | -43 Million USD | -556.221% |
| eFFECTOR Therapeutics, Inc. | -33.84 Million USD | -733.752% |
| IN8bio, Inc. | -30.33 Million USD | -830.135% |
| Kodiak Sciences Inc. | -277.32 Million USD | -1.75% |
| Annexon, Inc. | -143.72 Million USD | -96.333% |
| Adverum Biotechnologies, Inc. | -123.79 Million USD | -127.945% |
| Assembly Biosciences, Inc. | -64.64 Million USD | -336.493% |
| Avalo Therapeutics, Inc. | -23.44 Million USD | -1103.613% |
| Ionis Pharmaceuticals, Inc. | -353.73 Million USD | 20.229% |
| Eyenovia, Inc. | -25.4 Million USD | -1010.643% |
| Puma Biotechnology, Inc. | 32.64 Million USD | 964.507% |
| Conduit Pharmaceuticals Inc. | -5.56 Million USD | -4973.265% |
| Xilio Therapeutics, Inc. | -79.13 Million USD | -256.583% |
| Arcellx, Inc. | -89.88 Million USD | -213.946% |
| Cardiff Oncology, Inc. | -45.41 Million USD | -521.367% |
| Enanta Pharmaceuticals, Inc. | -137.2 Million USD | -105.656% |
| Regulus Therapeutics Inc. | -31.1 Million USD | -807.053% |
| Moolec Science SA | -6.65 Million USD | -4140.807% |
| Acumen Pharmaceuticals, Inc. | -61.13 Million USD | -361.538% |
| Geron Corporation | -193.94 Million USD | -45.493% |
| LAVA Therapeutics N.V. | -43.25 Million USD | -552.382% |
| Royalty Pharma plc | 1.49 Billion USD | 118.911% |
| Atea Pharmaceuticals, Inc. | -164.16 Million USD | -71.888% |
| Greenwich LifeSciences, Inc. | -9.32 Million USD | -2925.076% |
| TFF Pharmaceuticals, Inc. | -21.89 Million USD | -1188.784% |
| Mersana Therapeutics, Inc. | -170.95 Million USD | -65.056% |
| Humacyte, Inc. | -100.04 Million USD | -182.042% |
| Structure Therapeutics Inc. | -102.77 Million USD | -174.556% |
| 89bio, Inc. | -151.2 Million USD | -86.619% |
| PMV Pharmaceuticals, Inc. | -80.13 Million USD | -252.138% |
| Avenue Therapeutics, Inc. | -14.54 Million USD | -1840.681% |
| Genelux Corporation | -24.16 Million USD | -1067.701% |
| Trevi Therapeutics, Inc. | -33.92 Million USD | -731.81% |
| Lexicon Pharmaceuticals, Inc. | -171.75 Million USD | -64.294% |
| Notable Labs, Ltd. | -14.65 Million USD | -1825.189% |
| Liquidia Corporation | -73.38 Million USD | -284.518% |
| Mustang Bio, Inc. | -50.72 Million USD | -456.273% |
| Immunovant, Inc. | -282.7 Million USD | 0.189% |
| Quantum-Si incorporated | -111.17 Million USD | -153.821% |
| Arbutus Biopharma Corporation | -78.1 Million USD | -261.286% |
| DiaMedica Therapeutics Inc. | -21.26 Million USD | -1226.821% |
| Vera Therapeutics, Inc. | -102.01 Million USD | -176.61% |
| Acasti Pharma Inc. | -11.31 Million USD | -2394.475% |
| MiNK Therapeutics, Inc. | -22.92 Million USD | -1131.071% |
| Pasithea Therapeutics Corp. | -15.97 Million USD | -1665.872% |
| Xenon Pharmaceuticals Inc. | -214.05 Million USD | -31.824% |
| Elevai Labs, Inc. Common Stock | -3.66 Million USD | -7590.637% |
| NeuroBo Pharmaceuticals, Inc. | -15.88 Million USD | -1676.25% |
| Tempest Therapeutics, Inc. | -29.15 Million USD | -867.778% |
| Soleno Therapeutics, Inc. | -41.38 Million USD | -581.846% |
| PepGen Inc. | -84.76 Million USD | -232.887% |
| Moleculin Biotech, Inc. | -29.63 Million USD | -852.297% |
| United Therapeutics Corporation | 1.18 Billion USD | 123.814% |
| Nuvectis Pharma, Inc. | -22.89 Million USD | -1132.367% |
| Solid Biosciences Inc. | -104.31 Million USD | -170.503% |
| BriaCell Therapeutics Corp. | -32.8 Million USD | -760.077% |
| Immuneering Corporation | -58.41 Million USD | -383.07% |
| Lixte Biotechnology Holdings, Inc. | -5.09 Million USD | -5443.456% |
| Silo Pharma, Inc. | -3.85 Million USD | -7218.591% |
| Belite Bio, Inc | -31.66 Million USD | -791.041% |
| XOMA Corporation | -41.84 Million USD | -574.286% |
| ARS Pharmaceuticals, Inc. | -67.52 Million USD | -317.913% |
| Bionomics Limited | -17.89 Billion USD | 98.423% |
| Apogee Therapeutics, Inc. | -93 Million USD | -203.404% |
| Alpha Tau Medical Ltd. | 35.68 Million USD | 890.849% |
| uniQure N.V. | -282.87 Million USD | 0.246% |
| Cassava Sciences, Inc. | -105.95 Million USD | -166.311% |
| Estrella Immunopharma, Inc. | -7.31 Million USD | -3760.071% |
| Poseida Therapeutics, Inc. | -129.5 Million USD | -117.889% |
| Forte Biosciences, Inc. | -32.48 Million USD | -768.605% |
| Anebulo Pharmaceuticals, Inc. | -8.3 Million USD | -3296.117% |
| Enlivex Therapeutics Ltd. | -29.39 Million USD | -859.942% |
| Conduit Pharmaceuticals Inc. | -5.56 Million USD | -4973.265% |
| SeaStar Medical Holding Corporation | -14.21 Million USD | -1885.749% |
| FibroBiologics, Inc. Common Stock | -8.88 Million USD | -3074.429% |
| Altimmune, Inc. | -95.92 Million USD | -194.15% |
| Amicus Therapeutics, Inc. | -73.49 Million USD | -283.943% |
| Alpha Tau Medical Ltd. | 35.68 Million USD | 890.849% |
| Compugen Ltd. | -12.99 Million USD | -2071.913% |
| Peak Bio, Inc. | -1356.23 USD | -20805736.768% |
| Zevra Therapeutics, Inc. | -49.6 Million USD | -468.855% |
| Benitec Biopharma Inc. | -22.49 Million USD | -1154.669% |
| Spyre Therapeutics, Inc. | -242.3 Million USD | -16.455% |
| NKGen Biotech, Inc. Common Stock | -29.74 Million USD | -848.615% |
| Zura Bio Limited | -62.63 Million USD | -350.485% |
| PolyPid Ltd. | -22.86 Million USD | -1133.983% |
| Aileron Therapeutics, Inc. | -16.27 Million USD | -1633.688% |
| NKGen Biotech, Inc. Warrants | -29.74 Million USD | -848.615% |
| Instil Bio, Inc. | -159.16 Million USD | -77.28% |
| argenx SE | -425.04 Million USD | 33.614% |
| Immunome, Inc. | -109.53 Million USD | -157.623% |
| Compass Therapeutics, Inc. | -50.36 Million USD | -460.282% |
| Verona Pharma plc | -67.83 Million USD | -315.998% |
| enGene Holdings Inc. Warrants | -26.06 Million USD | -982.79% |
| Shattuck Labs, Inc. | -91.95 Million USD | -206.855% |
| CervoMed Inc. | -7.81 Million USD | -3511.657% |
| LENZ Therapeutics, Inc. | -73.11 Million USD | -285.96% |
| Plus Therapeutics, Inc. | -13.32 Million USD | -2018.272% |
| Dianthus Therapeutics, Inc. | -48.17 Million USD | -485.741% |
| Moolec Science SA | -6.65 Million USD | -4140.807% |
| Enveric Biosciences, Inc. | -16.44 Million USD | -1615.512% |
| Inovio Pharmaceuticals, Inc. | -135.22 Million USD | -108.668% |
| AnaptysBio, Inc. | -164.41 Million USD | -71.628% |
| Design Therapeutics, Inc. | -78.19 Million USD | -260.884% |
| Leap Therapeutics, Inc. | -87.04 Million USD | -224.186% |
| NeurAxis, Inc. | -6.66 Million USD | -4134.004% |
| Seelos Therapeutics, Inc. | -40.49 Million USD | -596.746% |
| Lumos Pharma, Inc. | -36.61 Million USD | -670.675% |
| Achilles Therapeutics plc | -75.25 Million USD | -274.958% |
| enGene Holdings Inc. Common Stock | -26.06 Million USD | -982.79% |
| 180 Life Sciences Corp. | -13.47 Million USD | -1993.675% |
| Opiant Pharmaceuticals, Inc. | 5.15 Million USD | 5572.42% |
| CERo Therapeutics Holdings, Inc. | -2.93 Million USD | -9520.745% |
| Nutriband Inc. | -4.87 Million USD | -5691.857% |
| ORIC Pharmaceuticals, Inc. | -110.78 Million USD | -154.717% |
| CG Oncology, Inc. Common stock | -55.44 Million USD | -408.891% |
| Fractyl Health, Inc. Common Stock | -50.83 Million USD | -455.069% |
| Rani Therapeutics Holdings, Inc. | -66.09 Million USD | -326.898% |
| MoonLake Immunotherapeutics | -54.12 Million USD | -421.358% |
| Palisade Bio, Inc. | -13.07 Million USD | -2058.952% |
| Tourmaline Bio, Inc. | -45.4 Million USD | -521.408% |
| Beam Therapeutics Inc. | -176.48 Million USD | -59.886% |
| Neurogene Inc. | -55.58 Million USD | -407.664% |
| Mirum Pharmaceuticals, Inc. | -109.15 Million USD | -158.511% |
| AEON Biopharma, Inc. | -48.42 Million USD | -482.657% |
| CARGO Therapeutics, Inc. Common Stock | -96.71 Million USD | -191.774% |
| Sesen Bio, Inc. | -25.9 Million USD | -989.1% |
| Enliven Therapeutics, Inc. | -83.52 Million USD | -237.817% |
| Kiora Pharmaceuticals, Inc. | -12.58 Million USD | -2141.816% |
| Iovance Biotherapeutics, Inc. | -460.55 Million USD | 38.732% |
| Taysha Gene Therapies, Inc. | -72.43 Million USD | -289.535% |
| Athira Pharma, Inc. | -125.46 Million USD | -124.902% |
| Vaccinex, Inc. | -22.88 Million USD | -1133.013% |
| HCW Biologics Inc. | -25.71 Million USD | -997.225% |
| XOMA Corporation | -41.84 Million USD | -574.286% |
| Nektar Therapeutics | -137.42 Million USD | -105.33% |
| Arvinas, Inc. | -401.5 Million USD | 29.72% |
| Tevogen Bio Holdings Inc. | -8843.03 USD | -3190831.163% |
| Merus N.V. | -156.54 Million USD | -80.249% |
| Omega Therapeutics, Inc. | -100.26 Million USD | -181.44% |
| Quince Therapeutics, Inc. | -34.62 Million USD | -715.064% |
| Rezolute, Inc. | -70.42 Million USD | -300.686% |
| Clene Inc. | -40.54 Million USD | -596.041% |
| Indaptus Therapeutics, Inc. | -16.37 Million USD | -1622.841% |
| BeyondSpring Inc. | -23.11 Million USD | -1120.797% |
| Synlogic, Inc. | -55.16 Million USD | -411.548% |
| Allarity Therapeutics, Inc. | -17.92 Million USD | -1473.847% |
| Phio Pharmaceuticals Corp. | -10.82 Million USD | -2506.938% |
| Peak Bio, Inc. | -1356.23 USD | -20805736.768% |
| Werewolf Therapeutics, Inc. | -40.5 Million USD | -596.677% |
| Krystal Biotech, Inc. | -109.72 Million USD | -157.161% |
| Karyopharm Therapeutics Inc. | -129.53 Million USD | -117.828% |
| SpringWorks Therapeutics, Inc. | -343.01 Million USD | 17.736% |
| Lipella Pharmaceuticals Inc. | -4.74 Million USD | -5845.592% |
| MannKind Corporation | 8.67 Million USD | 3351.613% |
| Ikena Oncology, Inc. | -75.41 Million USD | -274.153% |
| Cyclerion Therapeutics, Inc. | -9.64 Million USD | -2825.003% |
| Gyre Therapeutics, Inc. | -67.23 Million USD | -319.716% |
| Gossamer Bio, Inc. | -183.75 Million USD | -53.557% |
| CohBar, Inc. | -12.38 Million USD | -2177.755% |
| Cognition Therapeutics, Inc. | -50.72 Million USD | -456.295% |
| NRx Pharmaceuticals, Inc. | -27.58 Million USD | -922.855% |
| Legend Biotech Corporation | -439.48 Million USD | 35.794% |
| Mural Oncology plc | -194.63 Million USD | -44.974% |
| Biora Therapeutics, Inc. | -67.14 Million USD | -320.26% |
| PaxMedica, Inc. Common Stock | -16.14 Million USD | -1647.725% |
| Disc Medicine, Inc. | -91.12 Million USD | -209.657% |
| Champions Oncology, Inc. | -7.35 Million USD | -3735.984% |
| REGENXBIO Inc. | -268.12 Million USD | -5.239% |
| Ensysce Biosciences, Inc. | -10.71 Million USD | -2532.675% |
| Anavex Life Sciences Corp. | -55.75 Million USD | -406.089% |
| Cellectar Biosciences, Inc. | -38.96 Million USD | -624.257% |
| Edgewise Therapeutics, Inc. | -114.35 Million USD | -146.749% |
| Vaxart, Inc. | -83.34 Million USD | -238.554% |
| PharmaCyte Biotech, Inc. | -8.52 Million USD | -3211.91% |
| Aldeyra Therapeutics, Inc. | -42.79 Million USD | -559.379% |
| Cellectis S.A. | -106.62 Million USD | -164.64% |
| Longeveron Inc. | -21.02 Million USD | -1241.837% |
| Repare Therapeutics Inc. | -116.22 Million USD | -142.785% |
| Sarepta Therapeutics, Inc. | -267.82 Million USD | -5.358% |
| Inozyme Pharma, Inc. | -75.64 Million USD | -273.025% |
| Revolution Medicines, Inc. | -487.18 Million USD | 42.081% |
| Nymox Pharmaceutical Corporation | -6.65 Million USD | -4141.957% |
| Third Harmonic Bio, Inc. | -43.95 Million USD | -541.978% |
| ArriVent BioPharma, Inc. Common Stock | -74.59 Million USD | -278.301% |
| AN2 Therapeutics, Inc. | -69.63 Million USD | -305.22% |
| Anixa Biosciences, Inc. | -11.01 Million USD | -2462.665% |
| Vertex Pharmaceuticals Incorporated | 4.3 Billion USD | 106.551% |
| Denali Therapeutics Inc. | -196.69 Million USD | -43.455% |
| Revelation Biosciences, Inc. | -8.65 Million USD | -3159.627% |
| Veru Inc. | -93.78 Million USD | -200.883% |
| Corvus Pharmaceuticals, Inc. | -23.32 Million USD | -1109.546% |
| Cingulate Inc. | -22.75 Million USD | -1139.829% |
| Passage Bio, Inc. | -108.38 Million USD | -160.335% |
| Context Therapeutics Inc. | -25.07 Million USD | -1025.431% |
| Exicure, Inc. | -14.99 Million USD | -1781.668% |
| Day One Biopharmaceuticals, Inc. | -206.06 Million USD | -36.936% |
| Oramed Pharmaceuticals Inc. | -40.59 Million USD | -595.047% |
| Scinai Immunotherapeutics Ltd. | -9.71 Million USD | -2803.95% |
| Rhythm Pharmaceuticals, Inc. | -184.35 Million USD | -53.059% |
| Nuvalent, Inc. | -149.49 Million USD | -88.756% |
| ABVC BioPharma, Inc. | -8.21 Million USD | -3334.244% |
| Carisma Therapeutics, Inc. | -88.73 Million USD | -218.012% |
| Unicycive Therapeutics, Inc. | -20.77 Million USD | -1258.308% |
| OmniAb, Inc. | -69.41 Million USD | -306.481% |
| Anew Medical, Inc. | -1.3 Million USD | -21591.753% |
| Fennec Pharmaceuticals Inc. | -12.77 Million USD | -2109.498% |
| Lipocine Inc. | -17.93 Million USD | -1473.675% |
| Lexeo Therapeutics, Inc. Common Stock | -68.51 Million USD | -311.856% |
| Nautilus Biotechnology, Inc. | -76.15 Million USD | -270.542% |
| SAB Biotherapeutics, Inc. | -38.07 Million USD | -641.097% |
| G1 Therapeutics, Inc. | -39.52 Million USD | -613.879% |
| Bellerophon Therapeutics, Inc. | -22.38 Million USD | -1160.61% |
| Sage Therapeutics, Inc. | -579.84 Million USD | 51.336% |
| Ocugen, Inc. | -65.53 Million USD | -330.598% |
| Mind Medicine (MindMed) Inc. | -93.86 Million USD | -200.615% |
| Q32 Bio Inc. | -92.1 Million USD | -206.372% |
| Brainstorm Cell Therapeutics Inc. | -21.43 Million USD | -1216.176% |
| Alumis Inc. Common Stock | -158.17 Million USD | -78.395% |
| Equillium, Inc. | -14.52 Million USD | -1843.086% |
| Kyverna Therapeutics, Inc. | -62.4 Million USD | -352.16% |
| Coya Therapeutics, Inc. | -7.9 Million USD | -3470.322% |
| CNS Pharmaceuticals, Inc. | -18.86 Million USD | -1395.751% |
| Galera Therapeutics, Inc. | -46.95 Million USD | -500.999% |
| Evelo Biosciences, Inc. | -108.46 Million USD | -160.151% |
| Comera Life Sciences Holdings, Inc. | -11.97 Million USD | -2257.349% |
| Dominari Holdings Inc. | -21.79 Million USD | -1194.618% |
| Edesa Biotech, Inc. | -9.22 Million USD | -2959.551% |
| vTv Therapeutics Inc. | -25.5 Million USD | -1006.482% |
| Bio-Techne Corporation | 206.68 Million USD | 236.524% |
| Agios Pharmaceuticals, Inc. | -391.48 Million USD | 27.922% |
| Harmony Biosciences Holdings, Inc. | 192.03 Million USD | 246.943% |
| Prelude Therapeutics Incorporated | -132.27 Million USD | -113.321% |
| Candel Therapeutics, Inc. | -38.39 Million USD | -635.003% |
| iTeos Therapeutics, Inc. | -151.1 Million USD | -86.746% |
| Nkarta, Inc. | -131.65 Million USD | -114.337% |
| BioCardia, Inc. | -11.64 Million USD | -2323.351% |
| Iterum Therapeutics plc | -47.46 Million USD | -494.453% |